Acetylcysteine: all 450 studies that test it

Page 4 of 5. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.

• Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine DependenceCompletedNCT02994875Early Phase 1
• N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive DisordersStatus unknownNCT02972398Not applicable
• Comparisons of Human Embryonic Development Using Single Medium With and Without the Addition of AntioxidantsCompletedNCT02971878Not applicable
• Redox Status and Immune FunctionCompletedNCT02930031Not applicable
• N-acetylcysteine in the Treatment of Depressive Symptoms in Bipolar OffspringStatus unknownNCT02865629Not applicable
• Evaluation of Aerosolized Drugs Deposition During Mechanical VentilationCompletedNCT02818270Not applicable
• Glutathione Levels and CompulsivityCompletedNCT02794389Not applicable
• Effect of N-Acetylcysteine on Autologous Fat Graft SurvivalWithdrawnNCT02788292Phase 4
• NAC in CC Resistant PCOS After LODCompletedNCT02775734Phase 2/3
• A Prospective Study on Incidence and Prevention of Contrast-induced Nephropathy in CroatiaCompletedNCT02761577Phase 4
• Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced NephrotoxicityCompletedNCT02760901Phase 2
• Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic SurgeryActive, not recruitingNCT02750319Phase 3
• Relative Bioavailability of AR10 Compared to Reference ProductCompletedNCT02723669Phase 1
• A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar DepressionWithdrawnNCT02719392Phase 4
• A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral SolutionCompletedNCT02688361Phase 1
• Effect on Migraine Frequency of Combined Anti-oxidant Therapy: The MIGRANT Study.Status unknownNCT02629536Phase 3
• Neurobiological Adaptations and Pharmacological Interventions in Cocaine AddictionCompletedNCT02626494Phase 4
• Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)CompletedNCT02583672Phase 2
• Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteineCompletedNCT02505477Phase 4
• NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled TrialCompletedNCT02483143Phase 4
• NAC Trial for AnosmiaCompletedNCT02481609Early Phase 1
• The Effect of N- Acetylcysteine on Inflammatory and Oxidative Stress BiomarkersStatus unknownNCT02420418Not applicable
• Simethicone and N-acetylcysteine in Upper Endoscopy - Prospective Double-blinded Randomized Controlled TrialCompletedNCT02357303Phase 4
• N-acetylcysteine Effects on TetrahydrocannabinolTerminatedNCT02335060Early Phase 1
• NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar DepressionCompletedNCT02294591Phase 2
• Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NACCompletedNCT02259595Phase 1
• THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESSStatus unknownNCT02241876Phase 4
• N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary SyndromeCompletedNCT02239107Phase 4
• A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced HepatitisCompletedNCT02182167Phase 2/3
• Effectiveness of Routine Nebulization of Mucolytics and Bronchodilators During Mechanical VentilationCompletedNCT02159196Not applicable
• Fatty Liver Disease in Obese ChildrenCompletedNCT02117700Phase 1/2
• NAC to Prevent Cisplatin-induced Hearing LossCompletedNCT02094625Phase 1
• Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced NephropathyStatus unknownNCT02088502Phase 2/3
• Effect of Acetylcysteine in Pediatric Acute Pyelonephritis.CompletedNCT02080182Phase 2
• Treatment Resistant Epilepsy and N-Acetyl CysteineWithdrawnNCT02054949Not applicable
• Acute Renal Failure Post Liver TransplantationCompletedNCT01907061Not applicable
• The Role of S-nitrosohemoglobin in Regulating Systemic Blood Flow During Hypoxia and NormoxiaTerminatedNCT01905696Early Phase 1
• Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle NephropathyStatus unknownNCT01891292Not applicable
• N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in SchizophreniaCompletedNCT01885338Phase 1
• Effects of N-acetyl Cysteine During Percutaneous Coronary InterventionActive, not recruitingNCT01878669Phase 3
• Effects of N-acetyl Cysteine During Primary Percutaneous Coronary InterventionActive, not recruitingNCT01878344Phase 3
• Effectiveness of N-acetylcysteine on Preservation Solution During Liver TransplantationCompletedNCT01866644Phase 3
• N-Acetylcysteine in Patients With Sickle Cell DiseaseCompletedNCT01849016Phase 3
• Role of N-Acetylcysteine in Treatment of Bacterial VaginosisStatus unknownNCT01841411Phase 4
• A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia PurpuraCompletedNCT01808521Early Phase 1
• A Pilot Study of N-acetylcysteine in Patients With Sickle Cell DiseaseCompletedNCT01800526Phase 1/2
• Ischaemia-réperfusion During the Coronary Surgery With Beating HeartStatus unknownNCT01771978Phase 3
• Effect of N-acetylcystein in Myocardial InfarctionStatus unknownNCT01741207Phase 3
• Methylprednisolone N Acetylcysteine in Hepatic ResectionsTerminatedNCT01726465Phase 2
• N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve ReplacementCompletedNCT01704482Phase 2
• Diesel Exhaust and Mechanism of AsthmaCompletedNCT01699204Not applicable
• Efficacy Mechanism of N-acetylcysteine in Patients With Posttraumatic Stress DisorderWithdrawnNCT01664260Phase 2
• Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper EndoscopyCompletedNCT01653171Phase 4
• N Acetyl Cysteine for Cystinosis PatientsCompletedNCT01614431Phase 4
• N-Acetylcysteine for Patients With COPD and ChronicBronchitisStatus unknownNCT01599884Not applicable
• Effect of Antioxidant Cocktail in Beta-thalassemia/Hb E PatientsCompletedNCT01597765Not applicable
• Nephroprotective Effects of Carnitine and (PDE5) Inhibitor Agent Against Contrast Media-induced Nephropathy (CMN)Status unknownNCT01564303Not applicable
• Efficacy Study of add-on Therapy With N-Acetylcysteine in Resistant Obsessive-compulsive DisorderCompletedNCT01555970Phase 2
• Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on InflammationCompletedNCT01550432Not applicable
• Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of SchizophreniaCompletedNCT01506765Phase 1
• A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of AntioxidantsCompletedNCT01495260Phase 2
• Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis WithdrawalTerminatedNCT01439828Phase 2
• Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)Status unknownNCT01403506Phase 3
• Use of N-Acetylcysteine During Liver ProcurementCompletedNCT01394497Phase 2
• Effect of N-acetylcysteine on Prevention of Acute Kidney Injury in High Risk Patients Undergoing Off-pump Coronary Artery Bypass GraftCompletedNCT01394419Phase 4
• Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)CompletedNCT01381354Phase 1
• N-acetylcysteine to Prevent Renal FailureStatus unknownNCT01359722Not applicable
• Protective Effect of N-acetylcysteine Against From OtotoxicityCompletedNCT01271088Phase 2/3
• Effect of N-acetylcysteine on Renal Functioning of Chronic Kidney Diseases(CKD) Patients After General AnesthesiaStatus unknownNCT01251029Phase 1
• Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)CompletedNCT01232257Phase 3
• N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver ResectionCompletedNCT01223326Phase 4
• Inflammatory Mediators in Obstructive Sleep Apnoea Syndrome; Mechanisms of Production and the Effect of Long Term Antioxidants AdministrationStatus unknownNCT01188005Not applicable
• Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, PeruCompletedNCT01187108Phase 1/2
• Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial InfarctionCompletedNCT01160627Not applicable
• Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-AcetylcysteineStatus unknownNCT01138956Not applicable
• N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian CancerWithdrawnNCT01138137Phase 1
• Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-AcetylcysteineCompletedNCT01131468Phase 2
• Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in AdolescentsCompletedNCT01111734Phase 1
• Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) PatientsStatus unknownNCT01111422Phase 4
• Effects of N-acetylcysteine on Diabetic Foot OxygenationCompletedNCT01082445Phase 3
• NAC as a Potential Treatment for Methamphetamine DependenceCompletedNCT01063205Phase 1
• Compare Methadone Combined With N-Acetyl-Cysteine (NAC) and Methadone Alone for Opioids AstainingStatus unknownNCT01047956Phase 4
• ROS Signaling in Endothelial FunctionCompletedNCT01037465Not applicable
• N-acetylcysteine in the Treatment of Bulimia NervosaTerminatedNCT01033149Phase 3
• Contrast Agent-associated Nephrotoxicity in Intensive Care Unit PatientsStatus unknownNCT01017796Early Phase 1
• N-acetyl-cysteine (NAC) and Kidney Graft FunctionCompletedNCT00998972Phase 3
• The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung FunctionTerminatedNCT00996424Phase 4
• Protective Effect of N-acetylcysteine on Early Outcomes of Deceased Renal TransplantStatus unknownNCT00994305Not applicable
• Pilot Study to Assess the Effect of High Dose N-acetylcysteine (NAC) in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00969904Phase 4
• N-Acetylcysteine in Severe Acute Alcoholic HepatitisCompletedNCT00962442Phase 3
• N-Acetylcysteine and Milk Thistle for Treatment of Diabetic NephropathyCompletedNCT00915200Phase 2
• Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior ProblemsCompletedNCT00889538Not applicable
• N-acetylcysteine Plus Deferoxamine for Patients With HypotensionCompletedNCT00870883Phase 2
• The Use of Oral N-Acetyl Cysteine for the Treatment of Chronic Sinonasal SymptomsStatus unknownNCT00866866Phase 4
• Impact of N-Acetylcysteine on Oxidative Stress and Renal Function in Deceased Kidney Transplant RecipientsCompletedNCT00851708Not applicable
• N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed TomographyCompletedNCT00830193Phase 2/3
• The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast ExposureCompletedNCT00822263Not applicable
• Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney DiseaseCompletedNCT00808795Phase 3
• N-Acetyl Cysteine After Cervical CerclageCompletedNCT00787813Not applicable
• Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteineActive, not recruitingNCT00775476Phase 2

← Acetylcysteine overview